Molecular Testing for Infectious Diseases Market Business Impacts of COVID-19 | Growth by Top Companies and Global Industry 2030

Molecular Testing for Infectious Diseases Market: Introduction

Diagnostic testing is the backbone of a successful health care system which provides exact information that patients and health care providers need to make the right medical decisions. Diagnostics also offer accurate, quantitative metrics that guide the prevention, prediction, diagnosis, care, and effective management of health problems at any level.
Molecular testing is a revolutionary and complex diagnostic field, contributing to understandings of many disease-revolutionizing health care systems in study and diagnosis. Molecular testing identifies and tests the involvement of proteins or genetic material associated with a particular clinical disorder or illness, seeks to reveal the root causes of the disease and allows physicians to adapt patient treatment and promote the practice of ‘personalized medicine’.
Technological advancements coupled with government funding are expected to trigger the growth of the global molecular testing for infectious diseases market. Additionally, reduction in time and cost coupled with increase in need of customized molecular testing for infectious diseases augments the global molecular testing for infectious diseases market.

View Report : https://www.transparencymarketresearch.com/molecular-testing-for-infectious-diseases-market.html

Key Drivers and Restraints of Global Molecular Testing for Infectious Diseases Market

Rise in Prevalence of Infectious Diseases

According to the WHO infectious disease surveillance data, infectious diseases such as gonorrhea, tuberculosis, campylobacteriosis, covid-19 or coronavirus, and salmonellosis account for a majority of the infectious diseases throughout the globe, and E. coli infection is the most common food-related infection.
Thus, rise in prevalence of infectious diseases is likely to contribute to the growth of the molecular testing for infectious diseases market as these tests are among the most preferred methods for the detection of these diseases.

Increase in Public and Private Funding

The molecular testing for infectious diseases market witnessed a surge in funding that has expanded the real-time PCR research. Participants from different industries have funded several real-time PCR projects in academic and research institutions.
Further, Europa Organisation, the European funding organization, supports innovative companies in the development of new products and conducts annual PCR conferences to identify potential innovators of PCR technology
Similarly, in July 2016, Mobidiag Oy, a Finland-based molecular diagnostic company, received EUR 15 Mn loan (US$ 16.5 Mn) from European Investment Bank (EIB). This funding is expected to enable Mobidiag Oy to enhance its Amplidiag system, which includes multiplex tests for gastrointestinal infections. These tests employ real-time PCR to generate results.

Get PDF Sample Copy of Report: (Including TOC, List of Tables & Figures, Chart) : https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=76864

Insulin Infusion Pumps Segment to Dominate Global Market

In terms of application, the global molecular testing for infectious diseases market can be classified into HIV, hepatitis, sepsis, respiratory diseases, tuberculosis, sexually transmitted diseases, and others
Based on test type, the global molecular testing for infectious diseases market can be categorized into polymerase chain reaction, mass spectrometry, transcription mediated, amplification (TMA), hybridization, and others
Based on end-user, the global molecular testing for infectious diseases market can be divided into hospitals, research & academic institutes, diagnostic laboratories, and others

Europe to Dominate Global Molecular Testing for Infectious Diseases Market by End of Forecast Period

In terms of region, the global molecular testing for infectious diseases market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
The molecular testing for infectious disease market is largely centered in the U.S. The country’s dominance is due to major players such as Agilent Technologies and Abbott Laboratories that are based in the U.S.

Buy Now Report : https://www.transparencymarketresearch.com/checkout.php?rep_id=76864&ltype=S

The U.S accounts for significant market share; however, it is anticipated to be overtaken by Europe, owing to the rise in number of manufacturers in the region. Moreover, the molecular testing for infectious diseases market in Europe is witnessing a high growth rate due to increase in prevalence of infectious diseases, advancements in molecular techniques, and growing awareness and acceptance of personalized medicine and companion diagnostics.
Molecular diagnostics of infectious diseases, in particular, nucleic-acid-based methods, are the fastest growing field in clinical laboratory diagnostics. These applications are stepwise replacing or complementing biochemical, culture-based, and immunological assays in microbiology laboratories.

REQUEST FOR COVID19 IMPACT ANALYSIS – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=76864

Leading Players Operating in Global Molecular Testing for Infectious Diseases Market

The global molecular testing for infectious diseases market was highly fragmented in 2019. Key players operating in the global molecular testing for infectious diseases market are:

Abbott
Agilent Technologies, Inc.
Alere, Inc.
bioMérieux SA
Bio-Rad Laboratories, Inc.
Cepheid.
Danaher
F. Hoffmann-La Roche Ltd.
Hologic, Inc.
Meridian Bioscience, Inc.
PerkinElmer, Inc.
Randox Laboratories, Ltd.
QIAGEN
Siemens Healthcare GmbH
Thermo Fisher Scientific, Inc.

Global Molecular Testing for Infectious Diseases Market: Research Scope

Global Molecular Testing for Infectious Diseases Market, by Application

HIV,
Hepatitis
Sepsis
Respiratory Diseases
Tuberculosis
Sexually Transmitted Diseases
Others

Global Molecular Testing for Infectious Diseases Market, by Test Type

Polymerase Chain Reaction
Mass Spectrometry
Transcription Mediated Amplification (TMA)
Hybridization
Others

Global Molecular Testing for Infectious Diseases Market, by End-user

Hospitals
Research & Academic Institutes
Diagnostic Laboratories
Others

Global Molecular Testing for Infectious Diseases Market, by Region

North America

U.S.
Canada

Europe

Germany
U.K.
France
Italy
Spain
Rest of Europe

Asia Pacific

China
India
Japan
Australia & New Zealand
Rest of Asia Pacific

Latin America

Brazil
Mexico
Rest of Latin America

Middle East & Africa

GCC Countries
South Africa
Rest of Middle East & Africa

https://www.biospace.com/article/atopic-dermatitis-drugs-market-exponential-growth-of-biologic-drugs-favor-market-growth/